Senior insider sale
EVP, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$105.6K
6.21K shares
What this filing means
SHIELDS MATTHEW plans to sell 6.21K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $105.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/3/2025ACC: 0001973379-25-000179
Officer· EVP, Global Operations
Since Mar 2026
6.21K
Shares to sell
$105.6K
Approx. market value
16.20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RESTRICTED STOCK UNIT AWARD
COMPENSATION
6/3/2024
16.20KTotal acquired16.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/3/2024 | RESTRICTED STOCK UNIT AWARD COMPENSATION | 16.20K | — |
| Total | 16.20K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
6.21K
Market value
$105.6K
6/3/2025
Total
Units
6.21K
Value
$105.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/3/2025 | 6.21K | $105.6K | NYSE | Planned |
| Total | 6.21K | $105.6K | ||